Cargando…

Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells

The canonical Wnt/β-catenin pathway is activated in triple-negative breast cancer (TNBC). The activation of this pathway leads to the expression of specific target genes depending on the cell/tissue context. Here, we analyzed the transcriptome of two different TNBC cell lines to define a comprehensi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maubant, Sylvie, Tesson, Bruno, Maire, Virginie, Ye, Mengliang, Rigaill, Guillem, Gentien, David, Cruzalegui, Francisco, Tucker, Gordon C., Roman-Roman, Sergio, Dubois, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388387/ https://www.ncbi.nlm.nih.gov/pubmed/25848952 http://dx.doi.org/10.1371/journal.pone.0122333

Ejemplares similares

LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers
por: Maubant, Sylvie, et al.
Publicado: (2018)

TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
por: Maire, Virginie, et al.
Publicado: (2013)

LRP8 is overexpressed in estrogen‐negative breast cancers and a potential target for these tumors
por: Maire, Virginie, et al.
Publicado: (2018)

Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
por: Vinet, Mathilde, et al.
Publicado: (2019)

Detection of miRNA regulatory effect on triple negative breast cancer transcriptome
por: Martignetti, Loredana, et al.
Publicado: (2015)

Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses
por: El Khalki, Lamyae, et al.
Publicado: (2020)

Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells
por: Marty, Bérengère, et al.
Publicado: (2008)

PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer
por: Suresh, Samyuktha, et al.
Publicado: (2022)

AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells
por: Zajac, Olivier, et al.
Publicado: (2020)

HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers
por: El‐Botty, Rania, et al.
Publicado: (2023)

Wnt signaling in triple-negative breast cancer
por: Pohl, SÖ-G, et al.
Publicado: (2017)

Full Length Transcriptome Highlights the Coordination of Plastid Transcript Processing
por: Guilcher, Marine, et al.
Publicado: (2021)

Wnt signaling in triple negative breast cancer is associated with metastasis
por: Dey, Nandini, et al.
Publicado: (2013)

Clinical value of R-spondins in triple-negative and metaplastic breast cancers
por: Coussy, F, et al.
Publicado: (2017)

Triple-negative breast cancer: understanding Wnt signaling in drug resistance
por: Merikhian, Parnaz, et al.
Publicado: (2021)

Genomic Instability: A Stronger Prognostic Marker Than Proliferation for Early Stage Luminal Breast Carcinomas
por: Vincent-Salomon, Anne, et al.
Publicado: (2013)

A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer
por: Meyniel, Jean-Philippe, et al.
Publicado: (2010)

Performance evaluation of DNA copy number segmentation methods
por: Pierre-Jean, Morgane, et al.
Publicado: (2015)

Increased peak detection accuracy in over-dispersed ChIP-seq data with supervised segmentation models
por: Liehrmann, Arnaud, et al.
Publicado: (2021)

Wnt modulates MCL1 to control cell survival in triple negative breast cancer
por: Yang, Lixin, et al.
Publicado: (2014)

On optimal multiple changepoint algorithms for large data
por: Maidstone, Robert, et al.
Publicado: (2016)

Fast tree aggregation for consensus hierarchical clustering
por: Hulot, Audrey, et al.
Publicado: (2020)

A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapies
por: Carpen, Laura, et al.
Publicado: (2022)

SEPTIN3 Promotes Progression of Triple-Negative Breast Cancer via Activating Wnt Pathway
por: Wang, Guo-Zhou, et al.
Publicado: (2023)

Wnt ligand–dependent activation of the negative feedback regulator Nkd1
por: Larraguibel, Jahdiel, et al.
Publicado: (2015)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2018)

A comprehensive genomic and transcriptomic dataset of triple-negative breast cancers
por: Chen, Qingwang, et al.
Publicado: (2022)

Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer
por: Zhong, ZhenBin, et al.
Publicado: (2016)

Co-activation of Hedgehog and Wnt signaling pathways is associated with poor outcomes in triple negative breast cancer
por: Arnold, Kimberly M., et al.
Publicado: (2017)

Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
por: Gangrade, Abhishek, et al.
Publicado: (2018)

Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer
por: Abreu de Oliveira, Willy Antoni, et al.
Publicado: (2021)

Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
por: Cantini, Laura, et al.
Publicado: (2019)

Segmentor3IsBack: an R package for the fast and exact segmentation of Seq-data
por: Cleynen, Alice, et al.
Publicado: (2014)

Adjacency-constrained hierarchical clustering of a band similarity matrix with application to genomics
por: Ambroise, Christophe, et al.
Publicado: (2019)

Therapeutic Advantage of Targeting PRMT5 in Combination with Chemotherapies or EGFR/HER2 Inhibitors in Triple-Negative Breast Cancers
por: Dakroub, Rayan, et al.
Publicado: (2023)

Recent advances of transcriptomics and proteomics in triple‐negative breast cancer prognosis assessment
por: Li, Yuan, et al.
Publicado: (2022)

Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy
por: Zhang, Wei, et al.
Publicado: (2023)

Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy
por: Herrero-Vicent, Carmen, et al.
Publicado: (2017)

MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome
por: Medimegh, Imen, et al.
Publicado: (2014)

Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells
por: Bilir, Birdal, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fs12nqvob58tsf6pea11nfa69f